ACLARION INC (ACON) Stock Price, Quote, News and Overview
NASDAQ:ACON - Nasdaq - US6551874091 - Common Stock - Currency: USD
ACON Quote, Performance and Key Statistics
7.32
-0.28 (-3.68%)
The current stock price of ACON is 7.32 USD. In the past month the price decreased by -26.8%. In the past year, price decreased by -99.75%.
ACON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.49 | 39.24B | ||
| DOCS | DOXIMITY INC-CLASS A | 47.21 | 11.34B | ||
| WAY | WAYSTAR HOLDING CORP | 49.51 | 6.77B | ||
| CERT | CERTARA INC | 24.78 | 1.96B | ||
| SDGR | SCHRODINGER INC | N/A | 1.74B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 12.65 | 1.55B | ||
| PHR | PHREESIA INC | N/A | 1.53B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.34B | ||
| EVH | EVOLENT HEALTH INC - A | 24.39 | 1.09B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 837.09M | ||
| HSTM | HEALTHSTREAM INC | 43.51 | 836.83M |
Related stock screener links
About ACON
Company Profile
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Broomfield, Colorado and currently employs 6 full-time employees. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company. The firm leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The firm has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Company Info
ACLARION INC
8181 Arista Place, Ste 100
Broomfield COLORADO US
Employees: 5
Phone: 18332752266
ACLARION INC / ACON FAQ
What is the stock price of ACLARION INC today?
The current stock price of ACON is 7.32 USD. The price decreased by -3.68% in the last trading session.
What is the ticker symbol for ACLARION INC stock?
The exchange symbol of ACLARION INC is ACON and it is listed on the Nasdaq exchange.
On which exchange is ACON stock listed?
ACON stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACLARION INC stock?
7 analysts have analysed ACON and the average price target is 11993.7 USD. This implies a price increase of 163748.36% is expected in the next year compared to the current price of 7.32. Check the ACLARION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACLARION INC worth?
ACLARION INC (ACON) has a market capitalization of 4.25M USD. This makes ACON a Nano Cap stock.
How many employees does ACLARION INC have?
ACLARION INC (ACON) currently has 5 employees.
What are the support and resistance levels for ACLARION INC (ACON) stock?
ACLARION INC (ACON) has a resistance level at 7.61. Check the full technical report for a detailed analysis of ACON support and resistance levels.
Is ACLARION INC (ACON) expected to grow?
The Revenue of ACLARION INC (ACON) is expected to grow by 154.54% in the next year. Check the estimates tab for more information on the ACON EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACLARION INC (ACON) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACON, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACON, evaluating the profitability, health, valuation and growth aspects
- ACLARION INC (ACON) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACLARION INC (ACON) Sales and EPS estimates to see what analysts future expectations are.
- ACLARION INC (ACON) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACLARION INC (ACON) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACLARION INC (ACON) Stock Chart to make your own analysis
- ACLARION INC (ACON) Latest news and press-releases to stay up to date.
Does ACLARION INC (ACON) stock pay dividends?
ACON does not pay a dividend.
What is the Price/Earnings (PE) ratio of ACLARION INC (ACON)?
ACLARION INC (ACON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7480).
What is the Short Interest ratio of ACLARION INC (ACON) stock?
The outstanding short interest for ACLARION INC (ACON) is 10.19% of its float. Check the ownership tab for more information on the ACON short interest.
ACON Technical Analysis
ACON Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ACON. The financial health of ACON is average, but there are quite some concerns on its profitability.
ACON Financial Highlights
Over the last trailing twelve months ACON reported a non-GAAP Earnings per Share(EPS) of -7480. The EPS increased by 90.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -332.12% | ||
| ROE | -727% | ||
| Debt/Equity | 0 |
ACON Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ACON. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 19.83% and a revenue growth 154.54% for ACON